Home Canaccord Genuity Raises Illumina's Price Target to $150, Maintains 'Hold' Rating

Canaccord Genuity Raises Illumina's Price Target to $150, Maintains 'Hold' Rating

Jan 27, 2026 15:49 CST Updated 15:49
Illumina

Diagnostic Product Developer

Gelonghui January 27 | Canaccord Genuity raised Illumina's target price from $130 to $150 and maintained a "Hold" rating. (Gelonghui)